mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.2 |
0.0003 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0007 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0009 |